Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)

Jake Shortt; Uwe Platzbecker; Shuh Ying Tan; Paul Cannell; Teng Fong Ng; Chun Yew Fong; Sundra Ramanathan; Rajeev Rajagopal; Sophie Leitch; Robin Gasiorowski; Carolyn Grove; Douglas Lenton; Peter Tan; Courtney Dinardo; Ming Tat Ling; Si Cheng; Yuan Liu; Melannie Co; Wai Y. Chan; David Simpson; Andrew H. Wei

Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)

Jake Shortt
, Uwe Platzbecker
, Shuh Ying Tan
, Paul Cannell
, Teng Fong Ng
, Chun Yew Fong
, Sundra Ramanathan
, Rajeev Rajagopal
, Sophie Leitch
, Robin Gasiorowski
, Carolyn Grove
, Douglas Lenton
, Peter Tan
, Courtney Dinardo
, Ming Tat Ling
, Si Cheng
, Yuan Liu
, Melannie Co
, Wai Y. Chan
, David Simpson

Andrew H. Wei

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	144-144
Number of pages	1
Journal	Oncology Research and Treatment
Volume	45
Issue number	SUPPL 3
Publication status	Published - Nov 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Shortt, J., Platzbecker, U., Tan, S. Y., Cannell, P., Ng, T. F., Fong, C. Y., Ramanathan, S., Rajagopal, R., Leitch, S., Gasiorowski, R., Grove, C., Lenton, D., Tan, P., Dinardo, C., Ling, M. T., Cheng, S., Liu, Y., Co, M., Chan, W. Y., ... Wei, A. H. (2022). Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML). Oncology Research and Treatment, 45(SUPPL 3), 144-144.

@article{a9c5b963ecc34c7280b6b5b93ad3bfd4,

title = "Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)",

author = "Jake Shortt and Uwe Platzbecker and Tan, \{Shuh Ying\} and Paul Cannell and Ng, \{Teng Fong\} and Fong, \{Chun Yew\} and Sundra Ramanathan and Rajeev Rajagopal and Sophie Leitch and Robin Gasiorowski and Carolyn Grove and Douglas Lenton and Peter Tan and Courtney Dinardo and Ling, \{Ming Tat\} and Si Cheng and Yuan Liu and Melannie Co and Chan, \{Wai Y.\} and David Simpson and Wei, \{Andrew H.\}",

year = "2022",

month = nov,

language = "English",

volume = "45",

pages = "144--144",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S Karger AG",

number = "SUPPL 3",

}

Shortt, J, Platzbecker, U, Tan, SY, Cannell, P, Ng, TF, Fong, CY, Ramanathan, S, Rajagopal, R, Leitch, S, Gasiorowski, R, Grove, C, Lenton, D, Tan, P, Dinardo, C, Ling, MT, Cheng, S, Liu, Y, Co, M, Chan, WY, Simpson, D & Wei, AH 2022, 'Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)', Oncology Research and Treatment, vol. 45, no. SUPPL 3, pp. 144-144.

Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML). / Shortt, Jake; Platzbecker, Uwe; Tan, Shuh Ying et al.
In: Oncology Research and Treatment, Vol. 45, No. SUPPL 3, 11.2022, p. 144-144.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)

AU - Shortt, Jake

AU - Platzbecker, Uwe

AU - Tan, Shuh Ying

AU - Cannell, Paul

AU - Ng, Teng Fong

AU - Fong, Chun Yew

AU - Ramanathan, Sundra

AU - Rajagopal, Rajeev

AU - Leitch, Sophie

AU - Gasiorowski, Robin

AU - Grove, Carolyn

AU - Lenton, Douglas

AU - Tan, Peter

AU - Dinardo, Courtney

AU - Ling, Ming Tat

AU - Cheng, Si

AU - Liu, Yuan

AU - Co, Melannie

AU - Chan, Wai Y.

AU - Simpson, David

AU - Wei, Andrew H.

PY - 2022/11

Y1 - 2022/11

M3 - Abstract/Meeting Abstract

SN - 2296-5270

VL - 45

SP - 144

EP - 144

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - SUPPL 3

ER -